Viewing Study NCT00482261


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2025-12-27 @ 10:35 PM
Study NCT ID: NCT00482261
Status: COMPLETED
Last Update Posted: 2024-11-08
First Post: 2007-06-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-06
Start Date Type: ACTUAL
Primary Completion Date: 2010-08
Primary Completion Date Type: ACTUAL
Completion Date: 2014-02
Completion Date Type: ACTUAL
First Submit Date: 2007-06-03
First Submit QC Date: None
Study First Post Date: 2007-06-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-06
Last Update Post Date: 2024-11-08
Last Update Post Date Type: ACTUAL